Looks like you clickedhttps://cllsociety.org/2023/03/ash-2022-dr-john-allan-on-outcomes-for-chronic-lymphocytic-leukemia-cll-patients-with-undetectable-measurable-residual-disease-mrd-after-treatment-with-ibrutinib-plus-venetoclax/
If you do not want to visit that page, you can close this browser tab.
